Tarazi John M, Frane Nicholas, Sherman Alain E, Giordano Josh, Humphrey Emma K, White Peter B, Bitterman Adam
Department of Orthopaedic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA.
Department of Orthopaedic Surgery, Northwell Health - Huntington Hospital, Huntington, USA.
Cureus. 2024 Mar 1;16(3):e55354. doi: 10.7759/cureus.55354. eCollection 2024 Mar.
Introduction The authors examined if the transparency in industry payments to foot and ankle-trained orthopedic surgeons resulted in the following changes to the (1) median general payments to surgeons, (2) trend in median payments to surgeons across all subcategory payments, and (3) trend in median payments to surgeons in 11 regions of the United States. Methods A retrospective review of the Centers for Medicare and Medicaid Services (CMS) and Open Payments Database (OPD) was performed to identify all industry payments made by drug and medical device companies to orthopedic surgeons (N = 3,835) between January 1, 2014, and December 31, 2019. Descriptive statistics were calculated, and trend analyses in annual payments, number of payments to surgeons per year, payment subtypes, and regional distributions were analyzed. Results A total of 53,280 payments totaling $53,454,850.56 were made to orthopedic foot and ankle surgeons between 2014 and 2019. Mean and median payments were $1,003.28 and $60.19, respectively. Statistically significant differences in mean payment amounts were observed by year (p = 0.001) with a highly statistically significant, strong increase in the number of payments made over the six-year period (r = 0.97, p < 0.001). The greatest increases in median individual payments were observed for gifts (277.1%; r = 0.18, p = 0.05), education (250.6%; r = 0.17, p < 0.001), and royalties and licensing (72.1%; r = 0.05, p = 0.04). Statistically significant increasing trends in median payments over time were observed for the Northeast (p < 0.001) and South regions (p < 0.001). Discussion The results of this study demonstrate the increase in payments made across the six-year time period. The study demonstrates that there is a shift in the type of payments from speaker fees, entertainment, and lodging to education, gifts, honoraria, royalties, and consulting. Conclusion Since the OPD release, no significant decrease was identified in the financial relationship between foot and ankle surgeons and the industry; rather, an increase was observed. This increase in education, royalties, and consulting shows that more foot and ankle surgeons are getting involved in the industry, contrary to expectations. The partnership between industry and physicians can help to improve innovation and bring new ideas to the future of orthopedics.
引言 作者研究了向足踝专科整形外科医生支付行业款项的透明度是否导致了以下变化:(1)外科医生的一般支付中位数;(2)所有子类别支付中外科医生支付中位数的趋势;(3)美国11个地区外科医生支付中位数的趋势。
方法 对医疗保险和医疗补助服务中心(CMS)和开放支付数据库(OPD)进行回顾性审查,以确定2014年1月1日至2019年12月31日期间药品和医疗器械公司向整形外科医生(N = 3,835)支付的所有行业款项。计算描述性统计数据,并分析年度支付、每年向外科医生支付的款项数量、支付子类型和区域分布的趋势分析。
结果 2014年至2019年期间,共向足踝整形外科医生支付了53,280笔款项,总计53,454,850.56美元。平均支付和中位数支付分别为1,003.28美元和60.19美元。按年份观察到平均支付金额存在统计学显著差异(p = 0.001),在六年期间支付数量有高度统计学显著的强劲增长(r = 0.97,p < 0.001)。个人支付中位数增幅最大的是礼品(277.1%;r = 0.18,p = 0.05)、教育(250.6%;r = 0.17,p < 0.001)以及版税和许可(72.1%;r = 0.05,p = 0.04)。观察到东北部(p < 0.001)和南部地区(p < 0.001)的支付中位数随时间有统计学显著的增长趋势。
讨论 本研究结果表明在六年时间内支付有所增加。该研究表明支付类型从演讲费、娱乐和住宿费转向了教育、礼品、酬金、版税和咨询费。
结论 自OPD发布以来,未发现足踝外科医生与行业之间的财务关系有显著下降;相反,观察到有所增加。教育、版税和咨询方面的这种增加表明,与预期相反,越来越多的足踝外科医生参与到该行业中。行业与医生之间的合作有助于推动创新,并为骨科未来带来新想法。